Skip to main content
. 2020 Jun 16;8(3):436–445. doi: 10.1016/j.esxm.2020.06.002

Table 1.

Overall cohort stratified by the frequency of cannabis use

Characteristic Overall
The frequency of cannabis use
N (%) ≥3-5 times/wk ≤1-2 times/wk P value
Total 325 283 42
Age (years) .128
 <30 47 (14.5) 46 (16.3) 1 (2.4)
 30–39 74 (22.8) 62 (21.9) 12 (28.6)
 40–49 63 (19.4) 51 (18.0) 12 (28.6)
 50–59 53 (16.3) 47 (16.6) 6 (14.3)
 60+ 83 (25.5) 72 (25.4) 11 (26.2)
 Unknown 5 (1.5) 5 (1.8) 0 (0.0)
Race .693
 White 231 (71.1) 202 (71.4) 29 (69.0)
 Black/African 19 (5.8) 15 (5.3) 4 (9.5)
 Hispanic/Latino 44 (13.5) 38 (13.4) 6 (14.3)
 Other 31 (9.5) 28 (9.9) 3 (7.1)
Home region .187
 US West 115 (35.4) 104 (36.7) 11 (26.2)
 International 39 (12.0) 31 (11.0) 8 (19.0)
 US Midwest 35 (10.8) 27 (9.5) 8 (19.0)
 US Northeast 70 (21.5) 64 (22.6) 6 (14.3)
 US South 60 (18.5) 52 (18.4) 8 (19.0)
 Unknown 6 (1.8) 5 (1.8) 1 (2.4)
Relationship status .479
 Married 171 (52.6) 147 (51.9) 24 (57.1)
 In a relationship 67 (20.6) 62 (21.9) 5 (11.9)
 Single 86 (26.5) 73 (25.8) 13 (31.0)
 Unknown 1 (0.3) 1 (0.4) 0 (0.0)
 Weight (mean (SD)) 191.52 (47.02) 189.32 (43.70) 206.38 (63.86) .028
 Height (mean (SD)) 178.16 (8.11) 177.90 (8.03) 180.04 (8.50) .149
The number of PCP visits in the last 3 months .197
 0 170 (52.3) 153 (54.1) 17 (40.5)
 1 108 (33.2) 92 (32.5) 16 (38.1)
 2+ 47 (14.5) 38 (13.4) 9 (21.4)
Tobacco smoking history .118
 Never smoker 118 (36.3) 97 (34.3) 21 (50.0)
 Current smoker 52 (16.0) 48 (17.0) 4 (9.5)
 Former smoker 155 (47.7) 138 (48.8) 17 (40.5)
Cannabis use frequency <.001
 0 times/week 13 (4.0) 0 (0.0) 13 (31.0)
 1-2 times/week 29 (8.9) 0 (0.0) 29 (69.0)
 3-5 times/week 51 (15.7) 51 (18.0) 0 (0.0)
 6+ times/week 232 (71.4) 232 (82.0) 0 (0.0)
The primary method of consumption <.001
 Smoking flower 174 (53.5) 157 (55.5) 17 (40.5)
 Edibles 21 (6.5) 17 (6.0) 4 (9.5)
 Smoking concentrates or extracts 28 (8.6) 26 (9.2) 2 (4.8)
 Tincture or oils 28 (8.6) 21 (7.4) 7 (16.7)
 Unknown 4 (1.2) 0 (0.0) 4 (9.5)
 Vaping 57 (17.5) 53 (18.7) 4 (9.5)
 Other 13 (4.0) 9 (3.2) 4 (9.5)
Cannabis chemovar <.001
 THC dominant 193 (59.4) 173 (61.1) 20 (47.6)
 CBD:THC 1:1 96 (29.5) 89 (31.4) 7 (16.7)
 CBD dominant 30 (9.2) 21 (7.4) 9 (21.4)
 Unknown 6 (1.8) 0 (0.0) 6 (14.3)
The primary reason for use .001
 Medical 249 (76.6) 226 (79.9) 23 (54.8)
 Adult use 76 (23.4) 57 (20.1) 19 (45.2)
IIEF scores (mean (SD))
 Overall score 64.74 (9.10) 65.36 (8.02) 60.52 (13.84) .001
 Erectile domain 27.12 (4.42) 27.32 (4.10) 25.74 (6.04) .03
 Orgasm domain 8.95 (1.66) 9.08 (1.42) 8.12 (2.66) <.001
 Sexual desire domain 8.42 (1.60) 8.43 (1.50) 8.31 (2.20) .638
 Intercourse satisfaction domain 12.27 (2.45) 12.42 (2.26) 11.31 (3.37) .006
 Overall satisfaction domain 7.97 (2.05) 8.11 (1.87) 7.05 (2.87) .002
 Erectile dysfunction (SHIM < 21) 63 (19.4) 50 (17.7) 13 (31.0) .068
Total comorbidities .021
 0 106 (32.6) 94 (33.2) 12 (28.6)
 1 92 (28.3) 72 (25.4) 20 (47.6)
 2 64 (19.7) 60 (21.2) 4 (9.5)
 3+ 63 (19.4) 57 (20.1) 6 (14.3)

Comorbidities assessed included hypertension, diabetes, heart disease, arthritis, lung disease, kidney disease, thyroid disease, hypercholesterolemia, cancer, neurologic disease, liver disease, depression, and anxiety.

US = the United States; PCP = primary care physician, THC = tetrahydrocannabinol, CBD = cannabidiol, IIEF = International Index of Erectile Function; SHIM = Sexual Health Inventory for Men.